Dr. Sarah Noonberg Joins Maze Therapeutics as Chief Medical Officer

Maze Therapeutics has named Dr. Sarah Noonberg as Chief Medical Officer. Sarah is a board-certified physician-scientist. She was mostly recently with Nohla Therapeutics as its Chief Medical Officer, and served Prothena Corporation as Chief Medical Officer prior to that. She has also held leadership roles with BioMarin Pharmaceuticals, Medivation, and Chiron. Sarah currently sits on the Board of Directors for Neoleukin Therapeutics and Protagonist Therapeutics.

Maze Therapeutics is a biopharmaceutical company developing a broad portfolio of therapeutic candidates for a number of genetically defined diseases. It is based in South San Francisco, CA.